SRI is committed to bringing you the most current and relevant information as it relates to COVID-19.
Provides an algorithm for evaluation and treatment of pregnant patients during the crisis.
Franchi M, Bosco M, Garzon S, Laganà AS, Cromi A, Barbieri B, Raffaelli R, Tacconelli E, Scambia G, Ghezzi F. Management of obstetrics and gynaecological patients with COVID-19. It J Gynaecol Obstet. 2020;32(1):6-19.
Bizzarri M, Laganà AS, Aragona D, Unfer V. Inositol and Pulmonary Function. Could Myo-Inositol Treatment Downregulate Inflammation and Cytokine Release Syndrome in SARS-CoV-2? Eur Rev Med Pharmacol Sci. 2020;24(6):3426-3432.
The University of Cincinnati has published a survey titled "Clinical changes in Reproductive Medicine in light of the COVID-19 pandemic "aimed at assessing the preparedness and practice changes that have been implemented by Reproductive Health practices. This has been IRB approved with IRB ID 2020-0353.
The link can be found here: https://www.surveymonkey.com/r/3TFZ3L7
PRIORITY is a nationwide study of pregnant or recently pregnant women who are either under investigation for Coronavirus infection (COVID-19) or have been confirmed to have COVID-19. Women that are pregnant or have been pregnant within the last 6 weeks are eligible. This study is being done to help patients and doctors better understand how COVID-19 impacts pregnant women and their newborns. Health care providers may refer their patients on the website, or women may self-refer.
Study Website: https://priority.ucsf.edu/
Study email: email@example.com
The epidemic in Italy started on January 30 and, following the spread of cases throughout the whole country, the Government declared the lockdown. In the field of reproductive medicine, this led to recommendations from the major scientific societies to suspend in vitro fertilization (IVF) treatments.